• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺切除术对局部进展期可切除胃癌患者生存的影响

Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer.

作者信息

Chang Shih-Chun, Tang Chi-Ming, Le Puo-Hsien, Kuo Chia-Jung, Chen Tsung-Hsing, Wang Shang-Yu, Chou Wen-Chi, Chen Tse-Ching, Yeh Ta-Sen, Hsu Jun-Te

机构信息

Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.

Department of Gastroenterology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.

出版信息

Cancers (Basel). 2021 Mar 14;13(6):1289. doi: 10.3390/cancers13061289.

DOI:10.3390/cancers13061289
PMID:33799426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8001184/
Abstract

Whether gastric adenocarcinoma (GC) patients with adjacent organ invasion (T4b) benefit from aggressive surgery involving pancreatic resection (PR) remains unclear. This study aimed to clarify the impact of PR on survival in patients with locally advanced resectable GC. Between 1995 and 2017, patients with locally advanced GC undergoing radical-intent gastrectomy with and without PR were enrolled and stratified into four groups: group 1 (G1), pT4b without pancreatic resection (PR); group 2 (G2), pT4b with PR; group 3 (G3), positive duodenal margins without Whipple's operation; and group 4 (G4), cT4b with Whipple's operation. Demographics, clinicopathological features, and outcomes were compared between G1 and G2 and G3 and G4. G2 patients were more likely to have perineural invasion than G1 patients (80.6% vs. 50%, < 0.001). G4 patients had higher lymph node yield (40.8 vs. 31.3, = 0.002), lower nodal status ( = 0.029), lower lymph node ratios (0.20 vs. 0.48, < 0.0001) and higher complication rates (45.2% vs. 26.3%, = 0.047) than G3 patients. The 5-year disease-free survival (DFS) and overall survival (OS) rates were significantly longer in G1 than in G2 (28.1% vs. 9.3%, = 0.003; 32% vs. 13%, = 0.004, respectively). The 5-year survival rates did not differ between G4 and G3 (DFS: 14% vs. 14.4%, = 0.384; OS: 12.6% vs. 16.4%, = 0.321, respectively). In conclusion, patients with T4b lesion who underwent PR had poorer survival than those who underwent resection of other adjacent organs. Further Whipple's operation did not improve survival in pT3-pT4 GC with positive duodenal margins.

摘要

胃腺癌(GC)伴有邻近器官侵犯(T4b)的患者是否能从包括胰腺切除(PR)的积极手术中获益仍不清楚。本研究旨在阐明PR对局部晚期可切除GC患者生存的影响。1995年至2017年,纳入接受根治性胃切除术且有或无PR的局部晚期GC患者,并将其分为四组:第1组(G1),pT4b且未行胰腺切除(PR);第2组(G2),pT4b且行PR;第3组(G3),十二指肠切缘阳性且未行Whipple手术;第4组(G4),cT4b且行Whipple手术。比较G1与G2以及G3与G4之间的人口统计学、临床病理特征和结局。G2患者比G1患者更易发生神经周围侵犯(80.6%对50%,<0.001)。G4患者比G3患者有更高的淋巴结获取数(40.8对31.3,=0.002)、更低的淋巴结状态(=0.029)、更低的淋巴结比率(0.20对0.48,<0.0001)以及更高的并发症发生率(45.2%对26.3%,=0.047)。G1组的5年无病生存率(DFS)和总生存率(OS)显著长于G2组(分别为28.1%对9.3%,=0.003;32%对13%,=0.004)。G4组和G3组的5年生存率无差异(DFS:14%对14.4%,=0.384;OS:12.6%对16.4%,=0.321)。总之,行PR的T4b病变患者比行其他邻近器官切除的患者生存更差。对于十二指肠切缘阳性的pT3 - pT4 GC患者,进一步行Whipple手术并不能改善生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd6/8001184/7e0865ec79d4/cancers-13-01289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd6/8001184/54dd6e5cfcbf/cancers-13-01289-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd6/8001184/7e0865ec79d4/cancers-13-01289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd6/8001184/54dd6e5cfcbf/cancers-13-01289-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd6/8001184/7e0865ec79d4/cancers-13-01289-g002.jpg

相似文献

1
Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer.胰腺切除术对局部进展期可切除胃癌患者生存的影响
Cancers (Basel). 2021 Mar 14;13(6):1289. doi: 10.3390/cancers13061289.
2
Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?低分化可切除胰腺癌:直接手术切除是否值得?
Surgery. 2012 Sep;152(3 Suppl 1):S112-9. doi: 10.1016/j.surg.2012.05.017. Epub 2012 Jul 3.
3
Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.根治性切除的 pT4b 胃癌的预后与侵犯器官类型有关。
Ann Surg Oncol. 2012 Feb;19(2):494-501. doi: 10.1245/s10434-011-1987-6. Epub 2011 Aug 12.
4
[Feasibility, safety and long-term efficacy of laparoscopic total gastrectomy combined with distal pancreaticosplenectomy for T4b gastric cancer].腹腔镜全胃切除术联合远端胰腺脾切除术治疗T4b期胃癌的可行性、安全性及长期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 25;23(2):163-169. doi: 10.3760/cma.j.issn.1671-0274.2020.02.012.
5
Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion.对伴有胰头侵犯的手术治疗的pT4b期胃癌进行回顾性分析。
World J Clin Cases. 2021 Oct 16;9(29):8718-8728. doi: 10.12998/wjcc.v9.i29.8718.
6
Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.多脏器切除术治疗局部进展期胃癌:一项意大利多中心观察性研究。
JAMA Surg. 2013 Apr;148(4):353-60. doi: 10.1001/2013.jamasurg.309.
7
[Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].新辅助放化疗联合手术与直接手术治疗食管胃交界部SiewertⅡ型和Ⅲ型腺癌:一项前瞻性随机对照试验的长期预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):128-137. doi: 10.3760/cma.j.cn.441530-20201019-00565.
8
Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.局部晚期胃癌患者预防性腹腔内热灌注化疗的初步结果
Ann Ital Chir. 2013 Sep-Oct;84(5):551-6.
9
[Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].[肠系膜上静脉(第14v组)淋巴结清扫在局部进展期远端胃癌D2根治性胃切除术中的临床价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1136-1141.
10
Extended multiorgan resection in locally advanced gastric cancer: a single centre experience from south India.局部进展期胃癌的扩大多器官切除术:来自印度南部的单中心经验。
Trop Gastroenterol. 2013 Oct-Dec;34(4):259-63. doi: 10.7869/tg.144.

引用本文的文献

1
A comprehensive overview of gastric cancer management from a surgical point of view.从外科角度对胃癌治疗的全面概述。
Biomed J. 2024 Nov 18:100817. doi: 10.1016/j.bj.2024.100817.
2
Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series.纳武单抗用于HER2阴性局部晚期胃癌的围手术期化疗:病例系列
Surg Case Rep. 2024 Aug 28;10(1):200. doi: 10.1186/s40792-024-02001-w.
3
Gastric Cancer Invading the Pancreas: A Review of the Role of Pancreatectomy.胃癌侵犯胰腺:胰切除术作用的综述。

本文引用的文献

1
Role of Postoperative Complications in Overall Survival after Radical Resection for Gastric Cancer: A Retrospective Single-Center Analysis of 1107 Patients.术后并发症在胃癌根治术后总生存中的作用:1107例患者的回顾性单中心分析
Cancers (Basel). 2019 Nov 27;11(12):1890. doi: 10.3390/cancers11121890.
2
Impact of postoperative major complications on long-term survival after radical resection of gastric cancer.术后主要并发症对胃癌根治术后长期生存的影响。
BMC Cancer. 2019 Aug 23;19(1):833. doi: 10.1186/s12885-019-6024-3.
3
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
In Vivo. 2022 Sep-Oct;36(5):2014-2019. doi: 10.21873/invivo.12927.
4
Short-term safety and Long-term efficacy of multivisceral resection in pT4b gastric cancer patients without distant metastasis: a 20-year experience in China National Cancer Center.多脏器切除治疗无远处转移的pT4b期胃癌患者的短期安全性和长期疗效:中国国家癌症中心20年经验
J Cancer. 2022 Aug 15;13(10):3113-3120. doi: 10.7150/jca.75456. eCollection 2022.
5
Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone.转移性胃癌转化手术与先行手术加姑息化疗或单纯先行手术的疗效比较
J Pers Med. 2022 Apr 1;12(4):555. doi: 10.3390/jpm12040555.
EORTC-1203-GITCG - “创新”试验:曲妥珠单抗单药与曲妥珠单抗加帕妥珠单抗联合化疗在 HER2 阳性胃和胃食管交界处腺癌围手术期治疗中的疗效对比:EORTC 胃肠道肿瘤研究组、韩国癌症研究组和荷兰上消化道肿瘤组的一项随机 II 期分组试验。
BMC Cancer. 2019 May 24;19(1):494. doi: 10.1186/s12885-019-5675-4.
4
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗(FLOT4):一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
5
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.帕博利珠单抗单药或联合化疗作为晚期胃或胃食管结合部腺癌患者的一线治疗:来自 II 期非随机 KEYNOTE-059 研究的结果。
Gastric Cancer. 2019 Jul;22(4):828-837. doi: 10.1007/s10120-018-00909-5. Epub 2019 Mar 25.
6
Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies.根治性胃切除术治疗胃癌的术后并发症和预后:观察性研究的系统评价和荟萃分析。
World J Surg Oncol. 2019 Mar 18;17(1):52. doi: 10.1186/s12957-019-1593-9.
7
Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection.T4期胃癌患者根治性切除术后的预后因素及复发模式
J Cancer. 2019 Jan 29;10(5):1181-1188. doi: 10.7150/jca.28993. eCollection 2019.
8
Nationwide Outcome of Gastrectomy with En-Bloc Partial Pancreatectomy for Gastric Cancer.胃癌根治性胃切除术联合整块胰体尾切除术的全国性结局。
J Gastrointest Surg. 2019 Dec;23(12):2327-2337. doi: 10.1007/s11605-019-04133-z. Epub 2019 Feb 28.
9
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).纳武利尤单抗联合 S-1/卡培他滨加奥沙利铂治疗未经治疗的、不可切除的、晚期或复发性胃/胃食管结合部腺癌患者的安全性和有效性:一项随机、II 期试验(ATTRACTION-4)的中期结果。
Ann Oncol. 2019 Feb 1;30(2):250-258. doi: 10.1093/annonc/mdy540.
10
Pancreaticoduodenectomy for locally advanced gastric cancer: Results from a pooled analysis.局部进展期胃癌行胰十二指肠切除术:汇总分析结果。
Asian J Surg. 2019 Mar;42(3):477-481. doi: 10.1016/j.asjsur.2018.09.005. Epub 2018 Oct 10.